(Attorney advertising. Prior results do not guarantee a similar outcome.) As transvaginal mesh lawsuits are growing in number in state and federal courts, a recently-published study indicates transvaginal mesh surgeries at one point represented a majority of all prolapse procedures, the Rottenstein Law Group reports.
New York, NY (PRWEB) December 10, 2012
The study indicates that between 2005 and 2010 the use of vaginal mesh products comprised about 75 percent of all prolapse procedures, according to the Nov. 19, 2012, edition of the American Journal of Obstetrics and Gynecology. Researchers observed more than 78 million “person-years,” identifying 60,152 mesh prolapse procedures. Vaginal mesh surgeries were considerably more common than alternative pelvic organ prolapse procedures at all ages, according to the AJOG study.
“Though the study reflects the increased use of transvaginal mesh procedures during that specific time period, the increase of state and federal scrutiny could indicate a sea change in attitudes toward transvaginal mesh as a solution to pelvic organ prolapse,” said Rochelle Rottenstein, principal of the Rottenstein Law Group, which is currently evaluating cases related to serious transvaginal mesh side effects, including infection, vaginal bleeding, splitting of the vaginal tissue and harm to the vaginal wall. “I encourage anyone who thinks they might have been injured to contact the Rottenstein Law Group today.”
Read full story on PRWeb.com: Transvaginal Mesh Lawsuit Update: New Study Discusses Trends in Use of Vaginal Mesh to Treat Pelvic Organ Prolapse, Rottenstein Law Group Reports
New York, NY (PRWEB) December 10, 2012
The study indicates that between 2005 and 2010 the use of vaginal mesh products comprised about 75 percent of all prolapse procedures, according to the Nov. 19, 2012, edition of the American Journal of Obstetrics and Gynecology. Researchers observed more than 78 million “person-years,” identifying 60,152 mesh prolapse procedures. Vaginal mesh surgeries were considerably more common than alternative pelvic organ prolapse procedures at all ages, according to the AJOG study.
“Though the study reflects the increased use of transvaginal mesh procedures during that specific time period, the increase of state and federal scrutiny could indicate a sea change in attitudes toward transvaginal mesh as a solution to pelvic organ prolapse,” said Rochelle Rottenstein, principal of the Rottenstein Law Group, which is currently evaluating cases related to serious transvaginal mesh side effects, including infection, vaginal bleeding, splitting of the vaginal tissue and harm to the vaginal wall. “I encourage anyone who thinks they might have been injured to contact the Rottenstein Law Group today.”
Read full story on PRWeb.com: Transvaginal Mesh Lawsuit Update: New Study Discusses Trends in Use of Vaginal Mesh to Treat Pelvic Organ Prolapse, Rottenstein Law Group Reports
